Upstream Bio, Inc. UPB Payments For Repurchase Of Initial Public Offering
Payments For Repurchase Of Initial Public Offering at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfInitialPublicOffering.
The official record: Upstream Bio, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Upstream Bio, Inc.'s payments for repurchase of initial public offering.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Upstream Bio, Inc.'s payments for repurchase of initial public offering?
- Upstream Bio, Inc. (UPB) reported payments for repurchase of initial public offering of $0 in Q1 2026.
- How has Upstream Bio, Inc.'s payments for repurchase of initial public offering changed year-over-year?
- Upstream Bio, Inc.'s payments for repurchase of initial public offering decreased by 100.0% year-over-year, from $34K to $0.
- What does payments for repurchase of initial public offering mean?
- This metric tracks cash outflows associated with the repurchase or redemption of shares or rights related to the company's initial public offering. It reflects capital returned to investors or the settlement of obligations incurred during the IPO process. Monitoring this provides insight into the company's capital management strategy and potential dilution or liquidity impacts.